Rituximab Combining Bortezomib Versus Rituximab in Management of ITP

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The project was undertaking by Qilu Hospital of Shandong University and other 2 well-known hospitals in China. In order to report the efficacy and safety of rituximab combining with bortezomib for the treatment of adults with immune thrombocytopenia (ITP), compared to rituximab alone .
Epistemonikos ID: c9bffbc9910eda925fd0a8b70b879c61e92135ae
First added on: May 21, 2024